Postgraduates Members

Name of student

Postgraduate level (Msc/ MPharm/ PhD)

Area/ topic

Name of supervisor(s)

Abdul Kader    

PhD

Clozapine Pharmacogenomics and Pharmacometabolomics

Assoc. Prof. Dr. Baharudin Ibrahim
Dr. Dzul Azri Mohamed Noor

Kashvintha A/P Nagarajan

MSc

Metabolites profiling of Endophytic Diaporthe fraxini ED2 via NMR- based metabolomics

Dr. Tan Wen Nee
Assoc. Prof. Dr. Baharudin Ibrahim

Sim Xuan Yi

PhD

Time Course Study Of Protein And Lipid Profile In T2dm ( Type 2 Diabetics Mellitus ) Rats Models Upon High Calorie Food Intake

Prof. Dr. Gam Lay Harn
Assoc. Prof. Dr. Baharudin Ibrahim
Assoc. Prof. Dr. Vikneswaran A/L Murugaiyah
Dr. Mohd Nazri Bin Ismail

Ali Fadhel Ahmad

PhD

HLA genotypes and antiepileptic induced severe cutaneous adverse reactiond

Dr. Nur Aizati Athirah Daud
Dr. Dzul Azri Mohamed Noor

Shalini A/P Shanmugavelu

MSc

Psychological impact of COVID-19 on pregnant women

Dr. Nur Aizati Athirah Daud
Assoc. Prof. Dr. Balamurugan A/L Tangiisuran

Sohail Aziz

PhD

Pharmacometrics disease progression modelling from T2DM to diabetic nephropathy

Dr. Siti Maisharah Sheikh Ghadzi
Dr. Sabariah Noor Harun
Prof. Dr. Syed Azhar Syed Sulaiman

Irfanullah Khan

PhD

Time-to-event and disease progression modelling of chronic kidney disease (CKD) from Stage 3 to Stage 5 among geriatrics with T2DM and CKD using pharmacometrics approach

Dr. Amer Hayat Khan
Dr. Siti Maisharah Sheikh Ghadzi
Assoc. Prof. Dr. Kamarul Imran

Orwa Albitar

PhD

Development of pharmacokinetics and pharmacodynamic model of clozapine among schizophrenia patients.

Dr. Siti Maisharah Sheikh Ghadzi
Assoc. Prof. Dr. Baharudin Ibrahim
Assoc. Prof. Dr. Vikneswaran A/L Murugaiyah

Syed Ghouse Mohiuddin

PhD

Pharmacometric time-to-event modelling of T2DM to tuberculosis (TB) and the risks associated with TB treatment outcomes among patients with T2DM and TB 

Dr. Siti Maisharah Sheikh Ghadzi
Dr. Sabariah Noor Harun
Dr. Amer Hayat Khan

Mohd Rahimi bin Muda

PhD

Pharmacometrics modelling on the effect of rifampicin concentration and glucose level on the tuberculosis treatment outcomes with the incorporation of PKPD modelling and pharmacogenomics of rifampicin.

Dr. Siti Maisharah Sheikh Ghadzi
Dr. Sabariah Noor Harun
Prof. Dr. Syed Azhar Syed Sulaiman

Marwa Elsaeed ElHefnawy

PhD

Pharmacometric disease progression modelling in Stroke among patients with Type 2 Diabetes Mellitus

Dr. Sabariah Noor Harun
Dr. Siti Maisharah Sheikh Ghadzi
Assoc Prof. Dr Baharudin Ibrahim

Alharbi Hamad Rashdan A

PhD

Pharmacogenomics association with Carbamazepine response among epilepsy patient

Dr Dzul Azri Mohamed Noor
Assoc Prof Dr Baharudin Ibrahim

Guan Chin Leong

Msc

Predictive model of Recurrent stroke in Malaysian Population

Dr Sabariah Noor Harun
Dr Hadzliana Zainal

Chow Ngah Kuan

Msc

Association of Cigarette Smoking with Plasma Concentration of Efavirenz among HIV Positive Patients

Dr Amer Hayat Khan
Dr Sabariah Noor Harun

Mardhiya Darnalis

MSc

Evaluation of Gentamicin Population Pharmacokinetic Model for Malaysian Neonates and Infants

Dr Hadzliana Zainal

JD Yuvenesan Jagabalan

PhD

Pharmacokinetic modeling of single dose Kratom (mitragynine) in rats

Prof Dr Surash Ramanathan
AP Dr Vikneswaran Murugaiyah
Dr Hadzliana Zainal

Dinesh Sanggaran

MSc

Pharmacokinetic and Pharmacodynamic Modelling of Mitragynine in Pain Tolerance

Prof Dr Surash Ramanathan
Dr Hadzliana Zainal

Pharmacokinetic/Pharmacodynamic (PK/PD) of Intraperitoneal Vancomycin in CAPD Peritonitis -Correlation with Serum Level and Dose Optimization